Benicar HCT (Daiichi Sankyo, Inc.)
Welcome to the PulseAid listing for the Benicar HCT drug offered from Daiichi Sankyo, Inc.. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Daiichi Sankyo, Inc. |
| NON-PROPRIETARY NAME: | olmesartan medoxomil-hydrochlorothiazide |
| SUBSTANCE NAME: | OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2003-06-05 |
| END MARKETING DATE: | 0000-00-00 |
Benicar HCT HUMAN PRESCRIPTION DRUG Details:
| Item Description | Benicar HCT from Daiichi Sankyo, Inc. |
| LABELER NAME: | Daiichi Sankyo, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 2003-06-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65597-105_c9bd9866-9cea-4454-b62a-ee17af9c5a4e |
| PRODUCT NDC: | 65597-105 |
| APPLICATION NUMBER: | NDA021532 |
Other OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
